The Forces Behind Rising Drug Prices: Looking Past Martin Shkreli and Daraprim
Turing Pharmaceuticals, led by CEO Martin Shkreli, recently acquired Daraprim, a drug that treats a deadly parasitic infection, and promptly raised its price from $13.50 to $750. Shkreli earned himself the reputation of a “pharma bro” through his brash handling of the situation in the media and especially on Twitter, where he called critics…